Extragastrointestinal stromal tumor (EGIST)
Authors:
J. Kolařík; J. Drápela
Authors‘ workplace:
Chirurgické oddělení Okresní nemocnice Havlíčkův Brod, primář: MUDr. Jiří Drápela
Published in:
Rozhl. Chir., 2012, roč. 91, č. 4, s. 241-245.
Category:
Case Report
Overview
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Due to the presence of thyrosine kinase receptors within the tumor tissue, GIST is thought to originate from gastrointestinal pacemaker cells, the intersticial cells of Cajal. Tumors with the same morphological and imunohistochemical characteristics detected outside the gastrointestinal tract, are called extragastrointestinal stromal tumors (EGIST). Biological characteristics of these tumors is uncertain and the malignancy rates are difficult to predict. Surgical R0 resection in resecable tumors is the only option with the potential for complete cure. Nevertheless, the recurrence rates are high. Adjuvant biological treatment with imatinib, a thyrosine kinase inhibitor, reduces the risk of relapses. Imatinib administration is also the principal treatment method in metastatic GIST disorders. The article offers a short and complex overview of gastrointestinal stromal tumor (GIST) problematics and presents a case report of a patient suffering from EGIST of mesocolon transversum treated by R0 resection which was performed under multidisciplinary cooperation, with a specialist follow up.
Key words:
GIST – EGIST – KIT receptor – R0 resection – recurrence, biological treatment – multidisciplinary cooperation
Sources
1. Zezulová M, Melichar B. Adjuvantní terapie imatinibem u gastrointestinálních stromálních tumorů. Farmakoterapie 2010;10: 23–25, speciální příloha.
2. Nilson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumours: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era. Cancer 2005;103:821–9.
3. Castillo-Sang M, Mancho S. A malignant omental extra-gastrointestinal stromal tumor on a young man: a case report and overwiew of the literature, World Journal of Surgical Oncology 2008;6:50.
4. Jong-Han K, Yoon-Jung B. Multiple malignant extragastrointestinal stromal tumors of greater omentum and results of immunohistochemistry and mutation analysis: A case report. World J Gastroenterol 2007;6,28;13(24):3392–3395.
5. Kuroda N, Tanida N, Hirota S, Daum O, Hes O, Michal M, Lee GH. Familial gastrointestinal stromal tumor with ge rm line mutation of the juxtamembrane domain of the KIT gene observed in relatively young women, Ann Diagn Pathol 2010;6:19.
6. Kocáková I. Významná účinnost imatinib mesylátu u gastrointestinálního stromálního tumoru s multiorgánovým metastatickým postižením, Farmakoterapie 2010;10:33–35, speciální příloha.
7. Tezcan Y, Koć M. Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study, Med Oncol 2010; 10:17.
8. Kysela P, Kala Z, Novotný I. Chirurgická léčba pacientů s gastrointestinálním stromálním tumorem Farmakoterapie 2010;10: 14–18, speciální příloha.
9. Papalambros A, Petrou A, Brennan N, Bramis K, Felekouras E, Papalambros E. GIST suture-line recurrence at a gastrojejunal anastomosis 8 years after gastrectomy: can GIST ever be described as truly benign? A case report., World J Surg Oncol 2010;14;8(1):90.
10. Miettinen M, Monihan JM. Gatrointestinal stromal tumors primary in omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999;23: 1109–1118.
11. Dedemadi G, Georgoulis G. Extragastrointestinal stromal tumors of the omentum: review apropos of a case with a novel gain-of-function KIT mutation. J Gastrointest Cancer 2009;40:3–4.
12. Franzini C, Alessandri L. Extra-gastrointestinal stromal tumor of the greater omentum: report of a case and review of the literature. World J Surg Oncol 2008;6:25.
13. Zhang W, Peng Z. Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review, Gynecol Oncol 2009;11(33):399–401.
14. Pasku D, Karantanas A. Bilateral gluteal metastases from a misdiagnosed intrapelvic gastrointestinal stromal tumor. World J Surg Oncol 2008 Dec 30;6:139.
15. Reith JD, Goldblum JR. Extragastrointestinal stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 2000;13:577–85.
16. Deshaies I, Cherenfant J, Gusani NJ, Jiang Y, Harvey HA, Kimchi ET, Kaifi JT, Staveley-O’Carroll KF. Gastrointestinal stromal tumor (GIST) recurrence following Ther. Clin. surgery: review of the clinical utility of imatinib treatment. Ther Clin Risk Manag 2010;10:5;6:453–8.
17. Mou YP, Xu XW, Xie K, Zhou W, Zhou YC, Chen K. Laparoscopic wedge resection of synchronous gastric intraepithelial neoplasia and stromal tumor: A case report., World J Gastroenterol 2010; 21;16(39):5005–8.
18. Hasegawa J, Kanda T, Hirota S, et al. Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy. Int J Clin Oncol 2007;12:212–7.
19. Duffaud F, Salas S, Huynh T. Recent advances in the management of gastrointestinal stromal tumors, F1000 Med Rep 2010;5:11.
20. Linke Z, Prausová J. Léčba pokročilého gastrointestinálního stromálního tumoru, Farmakoterapie 2010;10:19–22, speciální příloha.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2012 Issue 4
Most read in this issue
- GIST: Current knowledge and treatment modalities
- Laparoscopic adrenalectomy – indications and selection criteria
- Prevention of parastomal hernia using laparoscopic introduction of a prosthetic mesh – initial experience
- Extragastrointestinal stromal tumor (EGIST)